Comparison of Thawing Embryos in Advance and on the Day of Transfer on Pregnancy Outcomes in FET Cycle

NCT ID: NCT04455191

Last Updated: 2020-07-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-01

Study Completion Date

2021-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Respectively for patients with repeated transplant failure and routine patients, Thawing frozen embryos in advance (18h) to extend the duration of embryonic development or thawing embryos on the day of transfer in the frozen embryo transfer cycle, to analyze which way can improve clinical pregnancy outcomes, is there a significant difference between the two ways or two types of patients?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Although in clinical practice, thawed embryos with appropriate development time will be selected strictly according to the number of days after ovulation, there are still two problems in actual clinical treatment: one is the embryonic factor, although the rate of embryonic development is generally the same, However, the phenomenon of delayed embryo division and development often occurs. The second is the endometrial factor. There are reports that a small number of people will move the transplant window forward, or the transplant window is narrow. This potentially creates the risk of embryo-endometrial mismatch. Based on this, the research team focused on patients with frozen embryo transfer cycles and put forward the strategy of "thawing embryos in advance and prolonging the development period of embryos properly" in an effort to achieve better repair of damage caused by embryo freezing and fine-tuning of embryo-endometrial interaction time. Therefore, it is necessary to compare thawing embryos in advance and thawing on the day of transfer on pregnancy outcomes in patients with repeated transplant failure and routine patients respectively.

The purpose of this study is to analyze which way can improve clinical pregnancy and birth outcomes, is there a significant difference between the two ways or two types of patients?

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

In Vitro Fertilization Frozen Embryo Transfer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Thawing Embryos in Advance

Thawing embryos one day in advance (16:00), 18h before embryos transfer (10:00).

Group Type EXPERIMENTAL

Thawing Embryos in Advance

Intervention Type PROCEDURE

Thaw Embryos one day in Advance

Thawing Embryos on the Day of Transfer

Thawing embryos on the day of transfer (8:00), 2h before embryos transfer (10:00).

Group Type EXPERIMENTAL

Thawing Embryos on the Day of Transfer

Intervention Type PROCEDURE

Thaw Embryos on the morning of transfer day.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thawing Embryos in Advance

Thaw Embryos one day in Advance

Intervention Type PROCEDURE

Thawing Embryos on the Day of Transfer

Thaw Embryos on the morning of transfer day.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged \<=35 years old;
* Regular menstrual cycle;
* Baseline follicle stimulating hormone (FSH) \<12 IU/L;
* Infertility, pure fallopian tube or/and male factor;
* At least 2 high-quality day 3 embryos or 1 high-quality day 5 blastocyst are used for ET.

Exclusion Criteria

* Patients with repeated transplant failure:
* Abnormal uterus, such as adenomyosis, endometriosis, endometrial polyps or Asherman syndrome;
* Abnormal ovaries, such as low ovarian response and polycystic ovary syndrome (PCOS);
* The endometrial thickness of FET day is \<7 mm.
Minimum Eligible Age

25 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jinan Central Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bin Wu

Reproductive medicine department

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yingchun Zhang, Dr

Role: STUDY_DIRECTOR

Jinan Central Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jinan Central Hospital Affiliated to Shandong University

Jinan, Shandong, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JianCH-RM2020-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.